Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Nov 6th, 5:21 AM EST
Ambler, Pennsylvania - Kimmel & Silverman, Pennsylvania’s oldest and largest automotive lemon law firm, has already resolved more than 2,500 PA Lemon Law
Via Law Firm Newswire · November 5, 2025
BioMedNewsBreaks — NextPlat Corp (NASDAQ: NXPL, NXPLW) Subsidiary PharmcoRx Awarded Multi-State Prescription Fulfillment Contract From DevotedDOc
NextPlat (NASDAQ: NXPL, NXPLW), a global provider of healthcare and technology solutions through e-commerce and retail channels, announced that its PharmcoRx subsidiary has secured an exclusive multi-state prescription fulfillment services contract from DevotedDOc, a virtual medical group specializing in urgent care, Medication-Assisted Treatment for opioid use disorder, and compounded alternatives to GLP-1 therapies for weight loss and hormone replacement therapy. PharmcoRx will begin serving patients in Florida and Georgia in November, with plans to expand nationally across its licensed territories. Vice President of Healthcare Operations Birute Norkute said the partnership underscores NextPlat’s commitment to improving access to rapid, affordable, and quality medical care for patients nationwide.
Via Investor Brand Network · November 5, 2025
Soligenix Inc. (NASDAQ: SNGX) Strengthens Financial Foundation to Advance Multiple Value Drivers
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases and biodefense programs, continues to fortify its financial position as it advances toward a series of pivotal and potentially transformational milestones. Following a series of strategic capital initiatives, including a $7.5 million public offering ( https://ibn.fm/QKXcv ), the company now reports a cash runway extending through the end of 2026, providing the resources needed to reach key clinical and regulatory inflection points across its diversified pipeline.
Via Investor Brand Network · November 4, 2025
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
A recent report published by the American Lung Association shows that only a tiny fraction of Americans that are eligible for lung cancer screening undergo the needed screening. This is despite the fact that lung cancer accounts for 20% of all deaths in America attributed to cancer .
Via Investor Brand Network · November 4, 2025
INDIANAPOLIS, IN - Nov 3, 2025 - Airport Limousine LLC, a premier provider of luxury ground transportation, today announced the enhancement of its black car and limousine services, setting a new benchmark for reliability, privacy, and safety in transfers between major U.S. cities and destinations across Indiana. With an exclusive focus on comfort and professionalism, Airport Limousine LLC is redefining the travel experience for business executives, families, and individuals.
Via AB Newswire · November 3, 2025
Soligenix Inc. (NASDAQ: SNGX) Strengthens Advisory Leadership in Cutaneous T-Cell Lymphoma
Soligenix (NASDAQ: SNGX), a clinical-stage biotechnology company focused on rare diseases and public health solutions, has rejuvenated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (“CTCL”), placing fresh expertise and leadership at the center of its HyBryte(TM) development program ( https://ibn.fm/ueKOC ). This strategic move signals the company’s deepening commitment to advancing its pipeline agents in CTCL and aligning clinical strategy with evolving standards of care.
Via Investor Brand Network · November 3, 2025
Sapu Nano Reveals the Initial In-Human Clinical Trial of Sapu-003, Intravenous Everolimus (Afinitor(R)) at Australian Translational Breast Cancer Symposium
Sapu Nano, which is in the Sapu family of companies, which was through GMP Biotechnology Limited, a joint venture between Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Dragon Overseas Capital Limited, recently revealed the company’s first in-human clinical trial of Sapu-003.
Via Investor Brand Network · November 3, 2025
IRVING, TEXAS – AJL International, a leader in executive and group chauffeured services, today announced the launch of its redesigned website, AJLInternational.com, alongside an expansion of its transportation offerings in Dallas, Fort Worth, and surrounding areas. With enhanced functionality and a user-friendly interface, the new platform reflects the company’s dedication to accessibility and operational excellence.
Via GetFeatured · October 31, 2025
London’s First Step Starts at Heathrow
London, UK, 31st October 2025, ZEX PR WIRE, Arriving at Heathrow Airport is often the first chapter of a London visit—whether for business, leisure, or connection to another UK city. For travellers who expect professionalism and comfort from the very start, Sky Bridge Cars
Via Zexprwire · October 31, 2025
How Rural Health Care is Being Impacted by the Federal Funding Landscape
Approximately 20% of people in the U.S. live in a rural area, and they face unique health challenges, such as higher rates of diabetes, obesity and high blood pressure. The recent changes to health care funding brought by the Big Beautiful Bill signed into law in early July are likely to impact rural areas adversely. Kimberly MacPherson, a health policy lecturer at UC Berkeley, highlights how rural health will be impacted .
Via Investor Brand Network · October 31, 2025
$37.5M Grant Announced to Boost Management of Infectious Diseases in the US
On October 15, NETEC (National Emerging Special Pathogens Training & Education Center) announced a grant of $37.5 million targeting HCIDs (High-Consequence Infectious Diseases). Laboratories that do work related to high-consequence pathology and pathogens were urged to call upon their employers to apply and be included among the 75 health care facilities that will be selected to receive part of this large grant .
Via Investor Brand Network · October 30, 2025
BioMedNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Highlights Blockchain Home-Equity Platform Launch in Exclusive Benzinga Interview
Beeline Holdings (NASDAQ: BLNE) CEO and Co-Founder Nick Liuzza discussed the company’s growth trajectory and industry outlook in an exclusive interview with Benzinga, following the launch of BeelineEquity, the nation’s first blockchain-powered home-equity platform. The platform enables homeowners—particularly baby boomers seeking liquidity—to sell fractional equity in their properties without taking on debt or monthly payments, with each transaction tokenized on blockchain. Liuzza told Benzinga that Beeline closed five equity transactions last week, expects about 25 more within 45 days, and is already taking 2026 applications amid strong demand. He said the company plans to scale nationwide as anticipated interest rate cuts improve housing affordability and create powerful tailwinds for the digital mortgage sector.
Via Investor Brand Network · October 28, 2025
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission
Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received final meeting minutes from its Sept. 18, 2025, virtual meeting with the U.S. Food and Drug Administration (FDA) regarding its lead product, AVERSA(TM) FENTANYL, an abuse-deterrent fentanyl transdermal system. The meeting with the Division of Anesthesiology, Addiction Medicine, and Pain Medicine confirmed the regulatory pathway as a 505(b)(2) New Drug Application and provided guidance on the reference listed drug and bridging strategy. The FDA also offered feedback on manufacturing validation, product specifications, and stability testing, along with expectations for in vitro manipulation and extraction studies to characterize AVERSA’s abuse-deterrent properties for potential NDA submission.
Via Investor Brand Network · October 28, 2025
What Patients Need to Know About the Remission Rate of Glioblastomas
Patients are overwhelmed when they are diagnosed with glioblastoma, the most deadly primary brain cancer. It resists existing treatments and recurs in all patients, with a relatively short survival time averaging 14-18 months. Understanding the rate of remission for this disease can therefore enable patients and their caregivers to have a clear picture of what to expect, and therefore be guided in making any decisions they need to make. We discuss some of the factors influencing remission in GBM.
Via Investor Brand Network · October 28, 2025
Soligenix Inc. (NASDAQ: SNGX) Research Highlights Breakthrough in High-Temperature Vaccine Stability
Current vaccines for Ebola and similar filoviruses face a major deployment barrier: Most require storage between 2°C and 8°C throughout transport, making them vulnerable to spoilage when exposed to the high ambient heat common in many outbreak regions ( https://ibn.fm/MZWfk ). Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in biodefense and rare disease vaccines, has published a peer-reviewed summary of new scientific data demonstrating long-term high-temperature stability of its protein subunit vaccine platform designed for Ebola and Marburg-related viruses ( https://ibn.fm/F2JpN ).
Via Investor Brand Network · October 28, 2025
October 25, 2025 -- Urtopia launches four new carbon fiber e-bikes this Black Friday, expanding its lineup to 11 models for every rider.
Via 24-7 Press Release · October 25, 2025
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Many existing cancer treatments, such as chemotherapy and radiation, don’t distinguish between cancer cells and healthy body cells, and the healthy cells killed alongside cancer cells result in harsh side effects. Researchers are constantly looking for new treatments that are better able to target cancer cells while leaving healthy cells untouched. A new study seems to have uncovered a therapy that could do just that .
Via Investor Brand Network · October 24, 2025
New Study Provides Insights on the Cost of Treating Firearm Injuries in America
A study whose findings were recently published has provided insights into the cost of treating injuries resulting from firearms, with a key finding being that Medicaid was billed for a little more than half of the total amount of money spent on these injuries during the period covered by the study.
Via Investor Brand Network · October 23, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Highlights Breast Cancer Awareness Month by Addressing Gaps in Screening and Advancing the IzoView Breast CT Solution
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device firm leading imaging-based solutions for better diagnosis, screening, and treatment of breast cancer patients, is bringing the challenges of current screening systems and the unique potential of the IzoView Breast CT Imaging solutions as part of efforts to mark Breast Cancer Awareness Month ( ibn.fm/Hml57 ).
Via Investor Brand Network · October 22, 2025
The Street spotlights five emerging micro-cap innovators reshaping their respective industries—from blockchain finance and AI cybersecurity to advanced mineral exploration, digital advertising, and regenerative biotechnology. As market interest accelerates toward companies driving innovation with measurable traction, these five companies below are capturing attention through strategic developments, leadership milestones, and breakthrough technologies that position them at the forefront of their respective sectors.
Via AB Newswire · October 21, 2025
Specificity, Inc. (OTCQB: SPTY), a leading digital marketing and ad tech innovator, announced the appointment of Robert Fedder as Chief Executive Officer. Fedder brings over 30 years of international leadership across Europe, the U.S., Australia, and Asia, with a proven record in scaling technology ventures and driving operational excellence.
Via AB Newswire · October 21, 2025
Researchers Develop Nanoparticles That Could Combat Scarring, Inflammation in ARLD
In the U.S., liver disease claims the lives of at least 52,000 people annually. Globally, statistics suggest that 1.5 billion individuals are affected by liver disease. However, ARLD, or alcohol-related liver disease, hasn’t garnered traction within the scientific community, until now .
Via Investor Brand Network · October 21, 2025
Nanomedicine’s Next Leap: Why Particle Size Matters in Cancer Drug Delivery
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is advancing precision nanomedicine with its proprietary Deciparticle(TM) platform, beginning human trials for Sapu003, a 20nm nanoparticle formulation of Everolimus (Afinitor(R)). This scientific briefing explores why particle size is critical to drug efficacy, how Oncotelic’s technology enhances tumor targeting, and how its rapid IND platform accelerates clinical development across multiple assets.
Via Investor Brand Network · October 21, 2025
Dubai, United Arab Emirates--(Newsfile Corp. - October 21, 2025) - OneClickDrive has released new insights from its marketplace data, revealing...
Via Newsfile · October 21, 2025
Bimmer Performance Center has officially moved into its new state-of-the-art facility at 5014 Departure Drive, Raleigh, bringing a higher level of care, comfort, and performance to BMW service in the Triangle.
Via AB Newswire · October 20, 2025